Sri Lanka is experiencing a rise in Chikungunya cases, with the highest number of infections being reported across the ...

Marketing authorization for the first EU vaccine to protect adolescents against chikungunya has been expedited for its public ...

Valneva has been awarded funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and EU to expand access to its recently approved vaccine for chikungunya, a potentially life ...

The world’s first chikungunya vaccine, developed by French pharmaceutical firm Valneva SE, has been approved in the UK by the ...

Earlier this week, the Company reported positive Phase 3 data in adolescents one year after a single vaccination, confirming the robust and long-lasting antibody response observed in adults 19. About ...

Valneva has shared positive results from a late-stage study of its single-dose chikungunya vaccine in adolescents aged 12 to 17 years. The vaccine, Ixchiq, is already approved in the US, Europe and ...

Jaipur: The seasonal diseases like Dengue, Malaria and Chikungunya are being reported even in winter in Rajasthan. In the first 13 days of January, 24 cases of Dengue, 21 cases of Chikungunya and ...

The UK approval marks the fourth regulatory approval Valneva has received for its single-shot chikungunya vaccine. The vaccine is currently approved in the United States (U.S.) 2, Europe 3 and Canada ...